GlassScriptPhysician profile
Yelena A Bishop
NPI 1053634493
$4,067.17
in general payments reported to CMS, 2019-2025
31 companies · $850 in 2025
The $850 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $477 · 2022: $739 · 2023: $1,110 · 2024: $890 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,850.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,019.26 | 2021-2025 | Venaseal, Turbohawk, Valiant Captivia |
| Abbott Laboratories | $534.03 | 2021-2025 | Esprit, Diamondback Peripheral, Jeti Peripheral Catheter |
| Boston Scientific Corporation | $442.53 | 2021-2025 | General - Vascular Intervention, Varithena Administration Pack, General - Atherectomy |
| Angiodynamics, INC. | $331.92 | 2021-2025 | Bioflo, Auryon Laser System 100-120 Vac |
| Tactile Systems Technology INC | $322.52 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Bard Peripheral Vascular, INC. | $186.06 | 2021-2024 | Rotarexs 6 F X 135 Cm |
| Janssen Pharmaceuticals, INC | $172.63 | 2021-2023 | Xarelto |
| Ethicon US, LLC | $158.45 | 2022-2024 | Prolene, Ethicon, Vistaseal |
| Organogenesis INC. | $139.38 | 2022-2025 | Cygnus Dual, Puraply |
| Mozarc Medical US LLC | $81.62 | 2023 | Chameleon |
| Cordis US Corp. | $81.42 | 2023-2025 | Mynx Control, Saber |
| Becton, Dickinson and Company | $80.18 | 2023-2025 | Venclose Maven Catheter, Lifestream, Rotarexs 6 F X 135 Cm |
| Integra Lifesciences Corporation | $45.51 | 2022 | |
| Urgo Medical North America, LLC | $44.60 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Urgoclean Ag |
| Inari Medical, INC. | $41.83 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $35.65 | 2022 | |
| Shockwave Medical, INC | $33.69 | 2025 | |
| Avita Medical Americas, LLC | $31.48 | 2024 | |
| Siemens Medical Solutions USA, INC. | $31.48 | 2021 | |
| Baylis Medical Technologies INC. | $29.10 | 2025 | |
| Endologix LLC | $28.04 | 2022 | |
| Kci USA, INC. | $25.54 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $25.35 | 2024 | Arcalyst |
| Philips North America LLC | $24.95 | 2022 | |
| Smith+Nephew, INC. | $19.75 | 2024 | Grafix |
| W. L. Gore & Associates, INC. | $19.74 | 2022 | |
| Cardiovascular Systems INC. | $18.19 | 2022 | |
| Convatec INC. | $17.29 | 2024 | |
| Baxter Healthcare | $17.10 | 2023 | Preveleak |
| Cook Medical LLC | $15.09 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yelena Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.